Thyroid Disorders in Pregnancy: What You Need to Know and How They Are Managed
Doctor examining a woman's neck for thyroid swelling during a clinical check-up consultation.
Thyroid disease is the second most common endocrine condition in pregnancy after gestational diabetes — and it carries consequences for both mother and baby if not well managed. India has a particularly high prevalence of thyroid disorders, making this a clinically important topic for pregnant women across Noida and Greater Noida.
Dr. Shachi Singh, consultant obstetrician at Prakash Hospital, Sector 33, Noida, explains.
Why Thyroid Function Matters More in Pregnancy
Thyroid hormones — particularly T4 and T3 — are essential for fetal brain and nervous system development, especially in the first trimester when the fetal thyroid is not yet functioning. The baby depends entirely on maternal thyroid hormones for the first 12 to 14 weeks of pregnancy. Thyroid hormone deficiency in this critical window — even mild, subclinical hypothyroidism — is associated with impaired fetal neurodevelopment.
Pregnancy itself significantly changes thyroid physiology:
- hCG (the pregnancy hormone) stimulates the thyroid — causing TSH to fall in the first trimester (normal in pregnancy)
- Oestrogen increases thyroid binding globulin (TBG) — increasing total T4 levels while free T4 remains stable
- Iodine requirements increase by 50% in pregnancy — supporting both maternal thyroid function and fetal hormone production
- The thyroid gland enlarges (goitre) in some pregnant women from the increased demand
Understanding these pregnancy-specific changes is essential for correctly interpreting thyroid test results in pregnancy.
TSH Reference Ranges in Pregnancy
Standard TSH ranges (0.4 to 4.0 mIU/L) do not apply in pregnancy. Pregnancy-specific ranges:
- First trimester: 0.1 to 2.5 mIU/L
- Second trimester: 0.2 to 3.0 mIU/L
- Third trimester: 0.3 to 3.5 mIU/L
A TSH that is "normal" by standard laboratory reference ranges may be elevated in the context of pregnancy. This is why pregnancy-specific interpretation matters.
Hypothyroidism in Pregnancy
Clinical (overt) hypothyroidism: TSH above the trimester-specific upper limit with low free T4. Requires immediate treatment with levothyroxine.
Subclinical hypothyroidism: TSH elevated above the trimester-specific range with normal free T4. The management of SCH in pregnancy is debated — but most guidelines recommend treating when TSH is above 2.5 to 4.0 mIU/L (depending on TPO antibody status and clinical context) because of fetal neurodevelopmental concerns.
Symptoms in pregnancy: Often indistinguishable from normal pregnancy symptoms — fatigue, weight gain, constipation, cold intolerance, cognitive fog. This is why TSH testing is recommended, not symptom-based diagnosis.
Effects on the baby if untreated:
- Impaired fetal brain development (first trimester maternal hypothyroidism)
- Increased miscarriage risk
- Preterm birth risk
- Low birth weight
Treatment: Levothyroxine — safe throughout pregnancy, essential when indicated. Doses typically need to increase in pregnancy (by approximately 25 to 30%) from the pre-pregnancy dose. TSH must be monitored every 4 to 6 weeks in the first trimester, then every trimester.
Postpartum thyroiditis: After delivery, some women develop thyroid dysfunction — an autoimmune phenomenon. Typically follows a pattern of hyperthyroidism (weeks 1 to 4 after delivery) followed by hypothyroidism (weeks 4 to 8). Usually self-resolving, but can cause significant symptoms. Women with TPO antibodies in pregnancy are at higher risk.
Hyperthyroidism in Pregnancy
Gestational transient hyperthyroidism: In the first trimester, hCG stimulates the thyroid. Women with very high hCG (twins, molar pregnancy, hyperemesis gravidarum) can have a transient, usually mild hyperthyroidism that resolves spontaneously in the second trimester. Does not require antithyroid medication.
Graves' disease: The most common cause of true hyperthyroidism in pregnancy. Caused by TSH receptor stimulating antibodies (TRAb) — these antibodies cross the placenta and can stimulate the fetal thyroid, causing fetal or neonatal hyperthyroidism.
Symptoms: Palpitations, heat intolerance, tremor, sweating, weight loss despite adequate intake, diarrhoea.
Treatment: Propylthiouracil (PTU) preferred in the first trimester (carbimazole carries a very small risk of specific fetal abnormalities in the first trimester). Carbimazole or methimazole from the second trimester. Beta-blockers (propranolol) for symptom control. Thyroid surgery is occasionally needed if medication cannot control hyperthyroidism.
Fetal monitoring: Women with Graves' disease in pregnancy require monitoring for fetal thyroid dysfunction — fetal growth scans and fetal heart rate assessment.
Screening for Thyroid Disease in Pregnancy
Universal TSH screening in early pregnancy is recommended in India by most expert guidelines — given the high prevalence of thyroid disease in the Indian population and the fetal consequences of undiagnosed hypothyroidism. TSH is ideally checked at the booking visit (8 to 10 weeks or as early as possible).
Obstetric Care in Noida and Greater Noida
Dr. Shachi Singh at Prakash Hospital, Sector 33, Noida, routinely screens for and manages thyroid disorders in pregnancy for women across Noida and Greater Noida.
To book a consultation with Dr. Shachi Singh, call: +91 97023 46853
Clinic Hours: Monday to Saturday, 9 AM – 6 PM | Sunday, 10 AM – 2 PM
Clinic Address: D-12A, 12B, Sector-33, G.B. Nagar, Noida, Uttar Pradesh 201301
This blog is for educational purposes only. Thyroid management in pregnancy must be individualised and closely monitored.
